HP
HighCape Partners
Micro VCModerateA growth equity firm that invests in companies that are commercializing high-margin life sciences products.
8
Investments
1
Exits
$56M
AUM
12.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for HighCape Partners.
Investment Thesis & Strategy
HighCape Partners invests in growth-stage life sciences companies commercializing high-margin products, leveraging their expertise to drive expansion and profitability.
Investment Activity
Deals per year over the last 5 years
1
20140
20151
20162
20172
2018Portfolio Companies
Selected investments from their portfolio of 8 companies
X
Xeris Biopharma Holdings
Biotech · Growth, 2018
V
Vaxart
Biotech · Growth, 2018
T
TherapeuticsMD
Healthcare · Growth, 2017
R
Revance Therapeutics
Biotech · Growth, 2017
P
Paratek Pharmaceuticals
Biotech · Growth, 2016
R
Retrophin
Biotech · Growth, 2014
Frequently Asked Questions
HighCape Partners focuses on Seed, Series A stage investments.
Related Investors
NextGen Venture Partners
Baltimore, United States · 61 deals
Bonsal Capital
Baltimore, United States · 35 deals
Anthem Capital Management
Baltimore, United States · 22 deals
Inner Loop Capital
Baltimore, United States · 10 deals
Spring Capital Partners
Baltimore, United States · 6 deals
Maryland Momentum Fund
Baltimore, United States · 4 deals